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Effects of Time-Variant Exposure on Toxic
Substance Response
by Paul F. Morrison*
Sources of time-variant exposure to toxic substances are identified and examined for their effects on
the estimation of response. It is shown that only time-averaged target tissue concentrations are required
to obtain rigorous risk estimates from the one-hit and multihit models. In contrast, detailed concentration
histories need to be retained throughout analyses involving two-event models with intermediate-stage
clonal growth advantage (clonal two-stage) and multistage models. Cumulative incidence ratios, based on
the exact to time-averaged treatment of concentration time dependencies, are evaluated for substances
whose toxic responses exhibit moderate (arsenic) and strong (ethylene dibromide) dependence on time of
actual exposure. These ratios reveal that time-averaged dose approximations may lead to several orders
of magnitude error in both the multistage and clonal two-stage models ifexposure periods are short, and
that 3.4-fold (arsenic) and 8-fold (ethylene dibromide) errors still exist even when an actual two-thirds
lifetime exposure is averaged over a full lifetime. Finally, the effects of time-variant exposure on risk
estimation due to migration and birth-death in an epidemiological setting are examined. A residence time
distribution calculation shows that, ifthese effects are ignored for a population orally exposed to arsenic
and characterized by an out-migration rate in excess of 5%/yr, response errors will exceed an order of
magnitude.
Introduction
The probability that an individual will exhibit a toxic
end point following exposure to a toxic substance is
usually estimated either from the responses of experi-
mental animals or from humans exposed to the sub-
stance in an epidemiological setting. For ease of com-
putation, these animals or humans are often assumed
toreceive aconstant doserate overthe exposureperiod.
However, in virtually all epidemiological settings and
in many animal experiments, this condition is not sat-
isfied. As a result, time-variant dose is often time av-
eraged to provide the constant dose rate needed for
simple computation. This procedure may or may not
lead to substantial error in estimating an individual's
probability of response and, hence, it requires exami-
nation.
Previous investigators have addressed the role of
time-dependent dosage in specific response models.
Whittemore and Keller (1) presented general expres-
sions for incidence rates derived from the multistage
model when dosage was time-dependent, as well as par-
ticular solutions when a constant dose rate was admin-
istered from birth to an arbitrary time. They applied
these step solutions to the analysis of tumor incidence
data from mice skin-painted with benzpyrene (2). Day
and Brown (3) provided additional multistage incidence
*Biomedical Engineering and Instrumentation Branch, Division of
Research Services, National Institutes of Health, Bethesda, MD
20892.
expressions for step-type dosage schedules when ex-
posure occurred late in life. Whittemore and Keller (1)
also presented a formal solution for including time-de-
pendent dosing in the modified multistage models of
Armitage and Doll (4) and Fisher (5), in which inter-
mediate stage cells were allowed to grow more rapidly
thannormalcells, buttheydidnotexercisethesemodels
over a range of specific time-dependent schedules.
More recently, Crump and Howe (6) developed so-
lutions for cumulative incidence predicted by the mul-
tistage model when dosage was time-dependent. Their
method was general in the sense that it held for dosage
patterns describable as a superposition ofsquare wave
forms. Since there was no restriction on the number of
square waves superimposed, theoretically, any time-
dependent dosage function couldbe described to ashigh
a degree of approximation as desired.
This report complements earlier work by discussing
the various sources of time-variant exposure, identi-
fying models that yield rigorous response estimates
from time-averaged doses, further identifying error
patterns in othermodelestimatesintroduced bytheuse
averaged-dose approximations, and assessing the mag-
nitude of migration-related effects in epidemiological
response. The dose-response models considered are the
one-hit, multihit, multistage, Weibull, and clonal two-
stage [modified multistage of Armitage and Doll (4)]
models. The principal toxic end point under consider-
ation will be cancer, but a few comments will also be
made about reproductive toxicity.P. F. MORRISON
Sources of Time-Variant Exposure
The response induced by a toxic agent ultimately
depends on the exposure to this substance or one ofits
metabolites at the target tissue. Time dependence in
this exposure may thus arise either from nonconstant
dosing at the level ofthe whole organism or from phar-
macokinetic transients atthe tissue levelresultingfrom
toxic substance distribution andmetabolism. Acommon
sourceofexposure variation atthewholeorganismlevel
is a time-dependent administration schedule in animal
experiments. This often results from alterations
imposed on an initial schedule during the course of an
experiment, as, for example, when excessive mortality
occurs in the animal population and the dose level must
be reduced. Other common sources of exposure time
dependence at the organism level include variable
release patterns oftoxic agents in environmental expo-
sure and variable exposure inanepidemiological setting
due to people migrating into and out of a geographical
region.
Pharmacokinetic events may occur overawide range
oftime scales and are thus a source oftime-dependent
exposure, yet the longest of these scales is often too
short to warrant formal inclusion of pharmacokinetic
transients indose-response analysis, particularly incar-
cinogenesis studies. Hydrophilic substances are typi-
cally cleared quiterapidlybythebodywithplasmahalf-
times on the order of a few hours. Hydrophobic mate-
rials may be characterized by larger half-times due to
their high retention in fatty tissues. However, even an
extremely fat-soluble species may be characterized by
a half-life that is long by pharmacokinetic standards,
but is still short compared to the length of continuous
administration often employed in cancer animal exper-
iments, periods of 1 year or more. For example, the
late plasmahalf-life of2,4,5,2',4',5'-hexachlorobiphenyl
in the dogis 19 days (7), a value farlargerthan encoun-
tered with most hydrophilic substances but much less
than a year. Hence, under conditions of nearly contin-
uous administration (e.g. daily gavage), many if not
most substances will reach steady-state tissue distri-
butions, and only pharmacokinetic steady-state concen-
trations need be employed in dose-response calcula-
tions.
On the other hand, situations do exist in which non-
steady-state pharmacokinetics play a significant role in
determiningtime-dependent exposure. Forexample, in
noncanine species such as the mouse, rat, and monkey,
2,4,5,2',4',5'-hexachlorobiphenyl is characterized by
extremely long time constants (7). The compound is
metabolized very slowly in these species and this, cou-
pled with its high fat solubility, allows it to continually
accumulate in the body over periods of administration
comparable to animal lifetimes. Thus, the pharmaco-
kinetics ofthis chemical species remain time-dependent
over most ofthe course of an animal experiment.
Another situation in which time-dependent pharma-
cokinetics may play a major role is in the area ofrepro-
ductive toxicity testing. In this case, reproduction tox-
icities such as the occurence of malformations are
assessed after relatively short periods of toxic agent
administration, for example over days 6 to 15 of ges-
tation inthe mouse. Formanyagents, this short admin-
istration period brings the time scale for induction of
reproductive lesions much closer to the scale of phar-
macokinetic transients and raises the possibility that
their description must be retained throughout any sub-
sequent dose-response analysis.
Concentration Time-Dependency in
Dose-Response Models
The detailed accounting ofthe dose dynamics arising
fromthesourcesoftime-variancejustpresentedishigh-
ly dependent upon the response model chosen to rep-
resent toxic response. We will show that the one-hit
and multihit models allow a rigorous estimation ofrisk
(incidence or cumulative incidence of response) from
only the time-averaged target tissue concentration,
while the multistage and clonal two-stage models gen-
erally require that detailed time-dependency be
retained throughout risk estimation. Numerical esti-
mates ofthe magnitude ofthese time-dependent effects
will be presented for carcinogenic end points attributed
to compounds whose response exhibits an intermediate
(arsenic) and strong (ethylene dibromide) dependence
on exposure time.
One-Hit Model
In this model, the probability X(t) for irreversible
transition of a cell from a normal to malignant state is
taken as proportional to the target tissue concentration
c(t), i.e., X(t) = a + bc(t). FromWhittemoreand Keller
(1), the differential equation forthe probability ofa cell
being normal at time t is
dpo(t)ldt = -X(t)po(t) Po(O) = 1 [1]
Solving this equation forpo, and noting that Pi = 1 -
po is the probability of this cell having undergone the
toxic transition, one obtains
rt
p1(t) = 1 - exp(-at - b c(t)dt)
Because the time-averaged dose <c> is defined as the
integral in this expression divided by t,
p1(t) = 1 - exp(-at - b < c > t) [2]
Thus, rigorous toxicity estimates made from the one-
hitmodelonlyrequireknowledgeoftheaveragedtarget
tissue dose.
Multihit Model
Thismodel(8)assumesthatkirreversiblealterations,
each with an identical transition probability X(t), must
occur in an individual before a toxic state is reached.
Differential equations for the probability of observing
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a normal individual (po) and individuals with n-hits (Pn)
are ofthe form of Equation 1 and
dpn(t)/dt = X(t)pn l(t) - X(t)pn(t) Pn(O) = 0
Recursive solutionoftheseequationsallows onetowrite
an expression for the probability P ofobserving a toxic
response consisting of k or more hits, i.e.,
X
1 k(t)
= Pn= 1 x exdx
n=k I(J)
where
t
A(t) = X(t)dt = at + b < c > t [3]
Because P depends only on the averaged target tissue
concentration through theA(t) limit, themultihitmodel,
like the one-hit, does not depend on the detailed time
pattern oftarget tissue dosing.
Multistage Model
This model (9) assumes that k irreversible hits must
occur in the order 0,1,. ... ,k - 1 with the transition
probability for each hit being Xj(t) = ai + bi c(t). No
cells except the final stage cells are assumed to undergo
growth. The general differential equations forthis mod-
el have been presented in Whittemore and Keller (1).
Ignoring the time for growth of tumor to detectable
size, the cumulative incidence of tumors P derived for
this model is
- t st2
P = 1- exp -NJ Xi-1(ti_1) f*J1(t)
rti
O o(to)dtodt
. . . dti 1 [4]
where N is the number of cells in a target organ. This
multiple integral results from the model's requirement
that the hits occur in aparticular sequence, and its form
generally does not allow the cumulative incidence of
tumors to be expressed in terms of <c>. Thus, detailed
time-dependence of the target tissue concentration
must be taken into account.
Whittemore and Keller (1) and Day and Brown (3)
evaluated P for special cases ofstep function exposure.
Crump and Howe (6) evaluated it for the more general
dose pattern of superimposed square waves, provided
that the toxic agent acts at no more than two stages.
Their method may be easily extended to other dosage
patterns such as the exponential decay functions
encountered in linear pharmacokinetics. Solutions
involve summations over incomplete gamma functions.
To demonstrate the magnitude of time-dependent
concentrationeffectsrelative totheirtreatment astime-
averaged quantities, we evaluate the ratioR ofthe life-
time cumulative incidence, computed for various time-
dependent tissue concentrations, to the corresponding
averaged concentration value. Thus,
P[c(t)] R P= P[<C>] [5]
The farther R is from unity, the poorer the dose-aver-
aged concentration approach. R is identically 1 for the
one-hit and multihit models, as tabulated in Table 1.
We have computed multistage R values appropriate
to skin cancerinduction by oral exposure to arsenic (10)
[presumably present as arsenate/arsenite in drinking
water (11)] and to induction of carcinoma of the rat
forestomach by ethylene dibromide (12), and tabulated
the results in Tables 1 and 2. Previous work has shown
that arsenical skin cancer prevalence exhibits a 3.88 +
0.33Weibull powerdependence on exposure timebegin-
ning at birth, a figure insignificantly different from 4
(13,14). Ethylene dibromide, ontheotherhand, exhibits
a stronger dependence on this exposure time, the cor-
responding power being6(6). Hence, R values forthese
Table 1. Ratio of actual to dose-averaged lifetime-response for
various models.a
Exposure initiation timeb
Model Early Late
One-hit 1 1
Multihit 1 1
Multistage
Arsenicc 2.4 1/27
Ethylene dibromided 3.0 1/250
Clonal two-stagee
Dose, ppm:
0 2.5 1/18
0.15 2.4 1/16
1.20 1.8 1/11
5.00 1.04 1/5.8
20.0 1 1/1.4
Infinity 1 1
aFixed exposure interval of one-third lifetime.
bEarly, initiation time at birth; late, initiation time two-thirds of
way through life.
'Arsenic multistage assumes four stages, the firstbeingdose relat-
ed.
dEthylene dibromide assumes six stages, the firstbeingdose relat-
ed.
eThis model is applied to arsenic exposure, assuming that both
stages are dose related.
Table 2. Ratio of actual to dose-averaged response: Effect of
exposure interval.'
Exposure Ratio (R)
Length of exposure initiation timeb EDBC As
Bolusd 0.0 6
0.57 1/11
0.86 1/2500
One-third lifetime 0.0 3 2.4
0.67 1/250 1/27
Two-thirds lifetime 0.0 1.5 1.5
0.33 1/8 1/3.4
aMultistage models.
bUnits offractional lifetime.
'Ethylene dibromide.
dFrom (6).
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chemical species provide examples of moderate and
strongdependence ofresponse ontime-dependent expo-
sure effects.
The cumulative incidences comprisingR, P[c(t)], and
P[<c>] were computed for arsenic and ethylene
dibromide from Equation 4 when only the first stage of
the four or six involved is affected by toxic agent (i.e.,
only b1 # 0). Earlier work showed that the assumption
ofasingle affected stage led togoodfits ofexperimental
response data (6,13). The multistageR values in Tables
1 and 2 were computed for two types ofdosage admin-
istration patterns. For simplicity, tissue pharmacoki-
netics were assumed to always be at steady state with
the current rate of administration. Table 1 presents
values for a fixed exposure period ofone-third lifetime,
with this period occurring either during the first third
oflife (early exposure) or the last third (late exposure).
BothP[c(t)] andP[<c>] wereevaluatedfromequations
ofCrump and Howe (6) where c(t) was the square wave
c(t) = tO°
and
S -' t <S2
otherwise
P[c(t)] = 1 - exp[-qotk - q,Zlk(t)]
[0
Zlk = Co (t - Sl)
(t - Sl)k _ (t - S2)k
t < s,
s t < S2
S2 < t
[Multistage ratios similar to our R values were com-
puted in (6) for ethylene dibromide but, generally, ref-
erence probabilities otherthanP[<c>] werereported.]
The multistage results for arsenic showthatinclusion
ofdose time-dependence leads to a 2.4-fold higher esti-
mate of cumulative incidence during early exposure
than time-averaged doses, and to a 27-fold lower esti-
mateduringlateexposure. Bycontrast, thetime-depen-
dent cumulative incidence of ethylene dibromide esti-
mated for late exposure is about 10-fold again lower,
i.e., 250-fold lower than the averaged-dose result. This
is a straightforward reflection of ethylene dibromide's
greater dependence of response on exposure time. As
observed by previous investigators in related analyses,
the much smaller R values for late exposure are a con-
sequence ofassumingthatonlythefirststageisaffected
by carcinogen; the time-averaged dose approach
improperly provides forlarge dosingearly inlife, allow-
ing many cells to undergo early first-stage transition
and to have much more time to reach the final trans-
formation stage than would be allowed by the actual
dosage pattern.
Table 1 presents examples ofthe magnitude oftime-
dependent dosage effects for a fixed exposure period
(one-third of a lifetime). These multistage results are
expanded in Table 2 to examine the effects of varying
the exposure period. As expected, the late bolus results
forethylene dibromide (6)showthemostextremediver-
gence of time-dependent and time-averaged doses,
nearly three orders ofmagnitude when the bolus is giv-
en 0.86 through a lifetime. The otherR values in Table
2 demonstrate that this divergence decreases as the
exposure time is lengthened, but that over a two-order
ofmagnitude difference still remains for late one-third
lifetime exposure and nearly an order ofmagnitude for
two-thirds ofalifetime exposure. Forthe arsenic exam-
ple, the effects are less dramatic due to this agent's
weaker dependence ofresponse on exposure time, but
they do not drop to less than an order of magnitude
until(late)exposurelengthenstotwo-thirds ofalifetime
or more. Hence, time-dependent concentration effects
may be extremely important in estimating multistage
responses, even when exposure periods are large frac-
tions of a lifetime.
Clonal Two-Stage Model
This modified multistage model (4) assumes thattoxic
response occurs after two irreversible stages and that
cells ofintermediate stage mayproliferate to advantage
over normal cells. This model is the deterministic limit
of the Moolgavkar and Venzon (15) two-event model
when the number of normal susceptible cells remains
constant (16). We include this model in our survey of
time-dependent concentration effects because itis more
biological than pure multistage models due to its allow-
ance of differential growth, and because it may even-
tually serve as a starting point for introduction ofacti-
vated oncogene effects. Furthermore, as we will apply
it, both normal and intermediate cells will be assumed
sensitive to the action of toxic agent, rendering the
cumulative incidence ratio R a function of tissue dose
and providing us with an extra dimension in which to
investigate time-dependent effects.
The mean equations for this model are
dNodt 0 O
dN1Idt = X,No + kNj
dN2/dt = X2N1
where No is the constant number ofnormal susceptible
cells, N1 isthenumberofintermediate cellswithgrowth
rateconstant k, N2isthenumberoftransformed clones,
and Xi = ai + bic(t). These equations maybeintegrated
to yield the probability, p2(t), that an individual cellwill
become a cancerous clone at time t
- N2(t) = t kt - t kt N20t)==X2(t2)e 2JX1(tl)e ldtdt2 [8]
Alternatively, the probability P ofthere being at least
onetumorouscloneinanindividualattime t(cumulative
incidence) may be calculated as
P(t) = 1 - exp(-NOp2) [9]
The Equation 8 result contrasts with Equation 4
because ofthe additional exponential growth terms.
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For constant dosing co over the entire observation
interval [O,t],
P = 1 - exp[(qo + qlco + q2c )(1 + kt - ekt)] [10]
where qo = NOa1a2 I k2, q1 = (a1b2 + a2b1)No I k2, and
q2 = Nob1b2 / k2.
For time-dependent tissue dosing, we again consider
the square wave tissue dosing pattern where c(t) = co
over the interval s8 S t < s2 and is zero otherwise (Eq.
6). Integration of Equation 8 for this pattern and sub-
stitution into Equation 9 yields an expression, P[c(t)],
for cumulative incidence as a function of a time-depen-
dent concentration:
P[c(t)] = 1 - exp[-NO(I1 + I2 + 13 + I4)]
I, = (a1a2/k)[(ekt - 1)/k - t]
0
12 = (b2a,cojk) (ekt - ekl)/k - t - s
(eks2 - eksl)/k - S2 + Sl
[0
I3 = (a2b1co/k) [ek(t-s1) - 1]/k - t + s
e-k(si+S2
- eksl]lk + s1 - S2
[0
14 = (bjb2c/k) e ksl(ekt - eksl)k + si - t
Ie-ksi(eks2 - eksl)lk + s
- S2 [11]
and the entries in brackets correspond to t < sl, s,
S t < s2, and t ¢ S2, respectively.
We again demonstrate the magnitude of the time-
dependent concentration effect on cumulative incidence
byformingthe ratio ofP[c(t)] to its corresponding time-
averaged value, i.e., R of Equation 5. We evaluate R
for arsenical skin cancer and for the same early [0,0.33]
and late [0.67,1] one-third lifetime exposure periods
used before with the multistage model.
The results are shown in Table 1 for six administered
dose levels, since R remains a function ofco when two
or more stages are carcinogen sensitive, as assumed in
this model. Parameter values were obtained by fitting
Equation 10 to the Tseng et al. data (10) (qo = 0, q1 =
0.0013 ppm-1, q2 = 0.0012 ppm-2, k = 0.071 yr-).
Because qo xa1a2 was zero, but q1 o a1b2 + a2b1 was
not, either a1 or a2 (but not both) was zero. The Tseng
et al. data could not discriminate between these pos-
sibilities andhenceweconsideredbothpossibilities. The
clonal two-stage entries in Table 1 are for the case a1
= 0. The entries in the early and late columns switch
for the case a2 = 0.
The arsenic data of Table 1 show this model to be
about as maximally sensitive to time-dependent con-
centration effects as the multistage. For the data of
Table 1 (a1 = 0), the greatest divergence betweentime-
dependent and time-averaged response calculations oc-
curs when the dose approaches zero and when exposure
is late, the time-averaged response being 18-fold that
of the true response. This compares to 27-fold for the
pure multistage. (The same comparison holds when a2
= 0 exceptthatthegreatest divergence occursforearly
exposure.) The data also show that as the dose level
increases, thetime-averagedresponsebecomesabetter
estimate, although it is still an order of magnitude in
error (11-fold) at the highest epidemiologic dose level
(1.2 ppm) reported by Tseng et al. (10). The R limit of
unity occurs at large doses for both early and late ex-
posures because these doses strongly affect both stages
ofarsenic transformation and drive the responses com-
prising both numerator and denominator ofR to 1, re-
gardless of the exposure pattern.
Time-Dependent Exposure Due to
Migration and Birth-Death: Effect on
Toxic Response Estimation
A special case of time-dependent dosage in the epi-
demiological setting involves the determination of ex-
posure periods by migration and birth-death patterns
of the exposed population. Because this is such a com-
mon circumstance in analyzing epidemiological data or
in estimating environmental risk, we next assess the
magnitude ofeffect that a typical human migration pat-
tern has on estimation of toxic response.
In essence, estimating the response of a human pop-
ulation to a toxic agent involves summing over the re-
sponses ofeach group ofpeople who have been exposed
for the same length oftime. Thus, ifthe residence time
distribution for this population can be ascertained, an
estimate of population toxic response may be made by
convolving the residence distribution with the proba-
bility of response for a particular residence time. We
therefore derive a residence time distribution for a sim-
ple population balance model, couple ittothemultistage
dose-response model, and examine predicted population
toxic response as a function ofmigration rate. Oral ar-
senic exposure will again serve as a numerical example.
We see that for large migration rates and intermediate
exposure time sensitivities, neglect of migration and
birth-death effects typically leads to an order of mag-
nitude response error.
Population Balance Model
To keep the analysis simple, assume that the exposed
region is a small geographic area in which people are
exposed to toxic agent at a constant level co. At any
time, this region is characterized by a residence time
density function, n(t,t'), where t is chronological time
beginning from the time that toxic agent emission
started, t' is an individual's residence time during this
period of emission (t' < t,t), and n(t') is the number of
people at time t who have lived in the area for a length
of time between t' and t' + dt'. People who have just
moved into the area or were just born there will have
t' = 0, whereas others may have been there since emis-
sion began and will have t' = t.
Ifwe assume that within the exposed population: (a)
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the rate ofin-migration is independent ofthe local pop-
ulation density (zeroth order in-migration rate); (b) the
rate of out-migration is proportional to the local popu-
lation density (first order out-migration); and (c) birth-
death rates are first-order processes uncorrelated with
either chronological or residence times (age-residence
time correlation is ignored for this order ofmagnitude
assessment), then a simple population balance model
may be written as
dt att (X + A)n(t,t') [12]
subject to the boundary conditions that
n(t,0) = + yn(t,t')dt' = ,B + yN(t) [13]
n(O,t') = NOB(t') [14]
where is the out-migration rate constant, A is the
death rate constant, ,B is the in-migration rate, -y is the
birth rate constant, No is the initial number of people
in the region, 8(t') is the Dirac delta function, and N(t)
is the total number of people in the region at time t
(defined by the second equality in Eq. 13). Equation 12
states that the chronological time rate ofchange in the
number of individuals per residence time interval dt'
(left-hand term) equalsthe rate atwhichindividuals age
intothis interval less those who age out ofit (first right-
hand term) less the number of individuals who die or
leave the area (second right-hand term). Equation 13
states that the flux of people just entering the region
at anytime t, thus having a zeroresidence time, isequal
to the constant rate ofin-migration (,B) plus the rate of
entry ofnewborns. Equation 14 merely states that the
number ofpeople initially living in the area at the time
ofemission start-up isNo0 and that these people are all
characterized by a zero residence time at t = 0.
The model may be solved for n(t,t') by the method of
characteristics in two time domains, t'
, t, t' < t (17).
When birth and death rates are nearly equal, -y = 8 and
the residence time distribution is found to be
n(t,t') = NO5(t' - t)e-(X+Y)t + e-(x+Y)t'H(t - t')
{I + yNoe x(tt) + Y[1 e`t-t') }
[15]
where H(x) is the Heaviside operator.
Expression for Toxic Response in a
Migrating-Birthing-Dying Population
As described above, the population response at time
t, np(t), involves integrating over the toxic responses
induced in each residence time cohort, i.e.,
nt Jt nt ,t
np(t) =lP(t',t) n(t,t') dt' + llP(t',t")
(X + A) n(t",t') dt'dt"
where P(t',t) is the probability that an individual will
develop a toxic response over the exposure time t - t'
to t. The first integral accounts for the toxic cases
remaining in the locale, and the second accounts for
those cases which occurred in persons who died or
moved to other geographical areas. (This formulation
assumes that the toxic response itself is not fatal, as is
the case with arsenical skin cancer.) For the case of
constant dose rate in the geographical region and for
the multistage model applied to low dose arsenic expo-
sure, P(t',t) can be identified as the low dose limit of
Equation 4 with one stage dose-related,
P(t,t) = Acot
k
where A is a grouped constant ofai's and bi's.
[17]
Magnitude of Migration Effect on
Response Estimate
To assess the magnitude ofmigration and birth-death
effects on response estimates, we determine the ratio
RM of the number of toxic cases in our geographical
region when migration is takeninto account to the num-
ber of cases when it is not. We assume that at the
beginning of exposure, the region contains the steady
state number of people N88 = p / X. RM is thus
R np(t) N88P(t,t)
with np(t) given by Equation 16 and P(t,t) by Equation
17 with t' = t. After performing the integrations in
Equation 16, one finds that
RM = exp(-y) + (2 + y)y-kG(k + 1,y)
- y-kG(k + 2,y) [18]
where y = (A + -y)tand G(a,x) istheincomplete gamma
function
G(a,x) =fXta-1e-tdt
Next we evaluate RM for arsenic, whose k is 4, for a
typical human population birth death rate, X = 1.43%/
yr, and arange ofout-migration rates X. Values chosen
for A were 1.4%/yr, 4.5%/yr, and 12.9%/yr. The obser-
vation period for toxic response has been taken as 30
years (rather than lifetime). No other parameters were
necessary since they cancelled out in forming the RM
ratio. The RM values are tabulated in Table 3.
TheRM values in Table 3 show that unless migration
effects are taken into account, estimates ofarsenic tox-
icity may be overpredicted by an order ofmagnitude at
Table 3. Ratio oftoxic responses with and without migration-
birth-death included.a
Out-migration rate X, %/yr RM
1.4 0.61
4.6 0.36
12.9 0.11
aMultistage, k = 4.
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high migration rates and about threefold at more mod-
erate migration rates. Had the dependence of arsenic
toxicity on exposure time been much less, with k ap-
proaching unity, then RM would also have been closer
to 1 and migration effects would have become unim-
portant. Conversely, migrationwould haveplayed astill
larger role for k values above 4. Finally, it should be
noted that these observations are quite general in that
they apply identically to any substance describable by
a Weibull dose-response relationship. This is suggested
by Equation 17, which is a special case ofthe low dose
Weibull A ctm 1. Had m not been 1, the same RM ratio
would have been obtained since cmwould have cancelled
in the numerator and denominator.
Summary
Both time-dependent administration schedules and
pharmacokinetic transients have been identified as
sources oftime-variant exposure, although, because of
their short time scale, pharmacokinetic transients (as
opposed to their steady states) are expected to play a
major role in risk estimation only for a limited number
ofsubstances orinshort-termassays. Ithasbeenshown
that, forone-hitand multihitmodels, rigorousestimates
oftoxic response may be obtained from time-averaged
doses only. On the other hand, it was shown that the
multistage and clonal two-stage models generally re-
quire explicit treatment of time-dependent tissue con-
centrations (local dose) or else large errors may be en-
countered, depending on the exact dosage pattern and
the sensitivity ofresponse to exposure time. For a sub-
stance, such as ethylene dibromide, which produces a
response strongly sensitive to exposure time, an order
of magnitude response error can be encountered even
when a two-thirds lifetime exposure is averaged over a
full lifetime. If arsenic is considered, a threefold error
is still encountered, although the response to this sub-
stance is two powers less dependent on exposure time.
It was also shown that the clonal two-stage model re-
quirestreatment ofconcentrationtimedependencydur-
ing estimation oftoxic response iferrors similar to the
multistage are to be avoided. In addition, response er-
rors in this model were shown to be dose dependent
due to the assumption of two dose-related stages. Fi-
nally, the introduction of time-variant exposure in ep-
idemiological populations by migration and birth-death
dynamics was examined for the magnitude ofits effect
on toxic response estimates. It was found that ifthese
dynamics were ignored and populations were assumed
static (a common assumption) overprediction oftrue re-
sponse occurs. Furthermore, this overprediction was
an order ofmagnitude for populations characterized by
average birth and death rates, out-migration rates in
excess of 5%/yr, and exposure to toxic agents with a
moderate sensitivity ofresponse to exposure time (e.g.,
those with a Weibull time-to-response exponent : 4).
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